Injuring a joint increases the odds of getting post-traumatic arthritis, or PTA. To date there are no therapies that slow the progression of arthritis after injury.
However, researchers at Duke University Health System have found a promising therapeutic approach to PTA using mesenchymal stem cells (MSCs). Their findings could lead to a therapy that would be used after joint injury and before signs of significant osteoarthritis, according to a Duke University statement.
Stem cell therapies and commercial applications will be discussed at the upcoming Stem Cells USA & Regenerative Medicine Congress, taking place in Cambridge, MA this September. Download the brochure for more information.